Progress of studies on cancer-related anemia in Chinese and Western medicine

Cancer-related anemia is a common complication in patients with a malignant tumor caused by the tumor itself or the tumor's treatment.It can seriously affect the quality of life of patients and even accelerate the progression of the tumor.Western medicine is often given a blood transfusion,erythropoietin,and iron agent in cancer-related anemia treatment,but there are also some problems such as increasing tumor-related mortality.Traditional Chinese medicine believes that cancer-related anemia's occurrence is related to the“Deficiency of Spleen and Kidney and Deficiency of Qi and Blood”,so clinical treatment is mainly to“Tonify Spleen and Kidney and Qi and Blood”.The combination of traditional Chinese and Western medicine is useful in cancer-related anemia's treatment,which provides a new idea and method for cancer-related anemia's clinical treatment.

Effect of spleen-invigorating, Qi-replenishing and blood-arresting formula on zebrafish models with simvastatin-induced hemorrhage caused by spleen failing to control blood, in terms of theory of Traditional Chinese Medicine

OBJECTIVE: To investigate the hemostasis effect of spleen-invigorating, Qi-replenishing and blood-arresting formula, on a zebrafish models with simvastatin-induced hemorrhage, and with symptom pattern caused by spleen failing to control blood, in terms of theory of Traditional Chinese Medicine(TCM).METHODS: In the first experiment, 60 AB strain wild type zebrafishes were randomly assigned into two groups: normal group and model group. The model group was treated with 50 μM simvastatinfor 24 h. The second experiment: The melanin allele mutated Albino strain zebrafishes were divided into normal, model, A group and B group. The observational parameters were as follows: blood flow, velocity of movement, hemorrhage ratio and improvement ratio of hemorrhage.RESULTS: Hemorrhage ratio: in the first experiment, brain hemorrhage ratio was 75%. In the second experiment, heart hemorrhage ratio was 65%.Blood flow: compared with the normal group,there was a significantly decrease in the model group(P < 0.001). Velocity of movement: in the first experimental, compared with the normal group,there was a significantly decrease in the model group(P < 0.001). Improvement ratio of hemorrhage: agents A had little effect in heart hemorrhage of the zebrafish; agents B could reduce heart hemorrhage ratio of the zebrafish, and increase the improvement ratio of hemorrhage.CONCLUSION: The manifestation of zebrafish model with simvastatin-induced hemorrhage is basically similar to that of the clinical symptom pattern caused by spleen's failure to control blood. The Spleen-invigorating, Qi-replenishing and Blood-arresting Formula can reduce the heart hemorrhage ratio of zebrafish induced by simvastatin, and increase the Improvement ratio of hemorrhage.

Clinical Study on Effect of Chinese Herbal Medicine for Supplementing Kidney and Qi and Activating Blood Circulation in Treating Intrauterine Growth Retardation of Fetus

Objective: To explore the therapeutic effect and the possible working mechanism in using Chinese herbal medicine (CHM) for supplementing Kidney and Qi, and activating blood circulation in treating intrauterine growth retardation of fetus (IUGR). Methods: Fifty-five cases of IUGR were divided into two groups, 30 cases in the CHM group treated with CHM and the 25 in the control group treated with amino acids. The effect of CHM treatment was observed and compared with that of the control group, normal pregnancy group and non-treated IUGR group. Results: Body weight of the newborns in the CHM was markedly higher than that in the control group. Not only the maternal fundal height (FH) and the abdominal circumference (AC), but also the fetal growth parameters, including biparietal diameter, head circumference (HC), and femur length (FL) in the CHM group increased much faster than those in the control group. After CHM treatment, the maternal serum levels of estriol (E3) and human placental lactogen (hPL) approached to those in the normal pregnancy group, but the control group,in comparison with the normal pregnancy group, was significantly different. The umbilical venous plasma concentration of essential amino acids in both treated groups improved, but the improvement in the CHM group was more significant than that in the control group. No apparent adverse effect of CHM was observed in either mother or fetus.Conclusion: CHM for supplementing Kidney and Qi and activating blood circulation was more effective in improving placental function and enhancing amino acid transportation than amino acid

单味中药有效成分治疗溃疡性结肠炎研究进展

研究表明,中药治疗溃疡性结肠炎不良反应少且复发率低,临床常用益气健脾、清热祛湿、活血化瘀、补血养阴类中药组方治疗,其主要药物的有效成分具有减轻炎症反应、修复黏膜损伤、调节肠道微生态、调节免疫反应等作用。本文对常用单味中药有效成分治疗溃疡性结肠炎的作用机制进行综述,为其临床治疗与中药新药研发提供参考。

从中医病机探析肺癌肿瘤微环境

肺癌是当今世界发病率和死亡率一直居高不下的恶性肿瘤,严重威胁着人民的生命健康。现代医学对肺癌的治疗基本经历了3场变革——传统的放化疗、精准靶向治疗、免疫治疗。其中免疫治疗主要通过适应性免疫系统来监视并杀伤肿瘤细胞,当下热门的嵌合抗原受体T细胞免疫疗法正是通过增强T细胞靶向杀伤肿瘤细胞的能力,达到抗癌的目的。而免疫细胞是肿瘤微环境(TME)的一部分,可见,干预TME已然成为攻克癌症的着眼点。根据中医取类比象思维推测肺癌TME,并将其病机归纳为:免疫逃逸类似营卫失和、肺卫不固;缺氧微环境类似肺脾肾气虚;酸性微环境类似痰湿阻肺;炎性微环境类似痰瘀癌毒积聚。提示以肺癌TME与中医病机契合点为指导,为中医药治疗肺癌提供遣方用药的参考依据。

基于中医血脉理论谈从脾论治糖尿病血管病变

糖尿病血管病变是糖尿病严重的慢性并发症之一,目前已成为糖尿病患者死亡和致残的主要原因,其巨额的医疗费用给家庭、社会带来沉重的经济负担。文章从血管与血脉的相关性出发,基于中医血脉理论,结合传统医学与现代医学观点,认为脾气虚,运化无力,气机不畅,脂浊不化,致痰浊、瘀血、热毒等病理产物壅滞血脉是糖尿病血管病变发生的重要原因,可累及多个靶器官。结合五脏一体观,从脾为四脏之长、脾与其他四脏的病变关系论述从脾论治糖尿病血管病变的理论依据以及古今医家从脾论治糖尿病血管病的临床思路,并将中西医思想融会贯通,突出从脾论治糖尿病血管病变的重要性。治疗上注重益气养阴、活血解毒、健脾化湿之法,为临床防治糖尿病血管病变提供新思路。

2型糖尿病性周围神经病合并胰岛素抵抗病案--仝小林院士教学查房实录

以广安门医院内分泌科中2型糖尿病性周围神经病合并胰岛素抵抗患者为例,邀请仝小林院士进行教学查房,对2型糖尿病性周围神经病合并胰岛素抵抗的中医辨治思路、疾病发展、诊疗要点进行阐述。仝院士在查房过程中强调辨别瘦型糖尿病和肥胖型糖尿病异同,把握疾病发展的不同趋势。糖尿病通常合并胰岛素抵抗,但瘦型糖尿病患者胰岛功能衰竭速度快,甚至初期便能表现出胰岛功能损伤,以脾虚为核心病机,在治疗中应注重补脾益气,从脾论治,运用态靶辨治体系,提高临床疗效。

从“虚”“郁”论治高血压前期

高血压前期是高血压病的潜伏期,已经出现代谢异常、血流动力学改变等亚健康状态。高血压前期病因病机与“虚”“郁”密切相关。脾虚是高血压前期的发病基础,气郁是病机发展的中间环节,痰、瘀、火等病理产物是发病的关键因素。治疗以健运脾胃、理气开郁为原则,化痰、活血、清热多法并用,同时注重日常调护,防治结合。

经方六君子汤加减对新发2型糖尿病伴脾气壅塞、痰瘀阻络型肥胖的干预作用

目的 探讨经方六君子汤加减对新发2型糖尿病伴脾气壅塞、痰瘀阻络型肥胖患者的临床效果。方法 选择2023年1月-2023年9月南京市六合区中医院收治的60例新发2型糖尿病合并肥胖患者随机分为观察组和对照组各30例。对照组予德谷门冬双胰岛素、盐酸二甲双胍治疗,观察组在对照组的基础上加用经方六君子汤加减治疗。比较两组治疗前后中医证候积分、腰围、体质量、身体质量指数(BMI)、空腹血糖(FBG)、餐后2 h血糖(2 hPBG)、糖化血红蛋白(HbA1c)、血脂四项(甘油三酯[TG]、总胆固醇[TC]、低密度脂蛋白[LDL]、高密度脂蛋白[HDL])、空腹胰岛素(FINS)、胰岛素抵抗指数(HOMA-IR)及不良反应。结果 治疗后,观察组总有效率明显高于对照组(P<0.05);两组中医证候积分、腰围、体质量、BMI、FBG、2 hPBG、HbA1c、TG、TC、LDL、HDL均明显改善(P<0.05),观察组均优于对照组(P<0.05)。治疗期间两组均出现低血糖1例,对照组腹泻1例,对症处理后好转,未出现明显血常规、肝肾功能异常。结论 新发2型糖尿病合并肥胖患者中加用经方六君子汤加减较单用德谷门冬双胰岛素联合盐酸二甲双胍片疗效更显著,可改善患者中医证侯积分、糖脂代谢相关指标等,不良反应少,效果满意。

朱莹基于“土得木而达”理论治疗溃疡性结肠炎经验

朱莹教授在论治溃疡性结肠炎时强调辨病论治与辨证论治相结合,溃疡性结肠炎临床常见证型为肝脾不和证、湿热郁滞证、肝郁血虚证、脾肾亏虚证、气滞血瘀证。朱教授治疗肝脾不和型溃疡性结肠炎常用柴芍六君子汤加减疏肝健脾;湿热郁滞型溃疡性结肠炎多用香砂六君子汤加黄芩、黄连、苦参、蒲公英清利湿热、调和肝脾、祛湿止泻;肝郁血虚型溃疡性结肠炎常用逍遥散、四物汤化裁;脾肾亏虚型溃疡性结肠炎常用四君子汤合参苓白术散加补骨脂、肉桂、熟地黄、杜仲、干姜等中药温补脾肾;气滞血瘀型溃疡性结肠炎运用分期祛瘀通络之法,在瘀病初期运用丹参、川芎、桃仁等配合白芍达到行气活血、养血合营、缓急止痛之效;滞瘀同病期配伍莪术、牛膝、牡丹皮以行滞通络;虚瘀同病期常用地龙、土鳖虫等血肉有情之品配合山药、当归以搜风通络、攻积破瘀、补脾益气,从而起到标本兼治之功。

滋肾补脾益气合祛湿活血化浊汤治疗脾肾气虚兼湿浊血瘀证糖尿病肾病患者的疗效观察

目的 探究滋肾补脾益气合祛湿活血化浊汤治疗脾肾气虚兼湿浊血瘀证糖尿病肾病(Diabetes nephropathy,DN)患者的临床价值。方法 选取2021年6月—2022年12月期间北京中医医院怀柔医院收治的DN患者90例,依据简单随机数字表法分为对照组和研究组,每组各45例。常规干预基础上对照组采取西医治疗,研究组在对照组基础上采取滋肾补脾益气合祛湿活血化浊汤,均治疗1个月。观察比较两组患者临床疗效、不良反应发生情况,治疗前后中医证候积分、肾功能[血肌酐(Serum creatinine,Scr)、血清尿素氮(blood urea nitrogen,BUN)、24 h尿蛋白定量]水平、血清同型半胱氨酸(Homocysteine,Hcy)及白细胞介素-6(Interleukin-6,IL-6)水平。结果 治疗后研究组临床总有效率93.33%(42/45)明显高于对照组77.78%(35/45),差异有统计学意义(P<0.05)。治疗后两组患者主症及次症分值均较治疗前降低,差异有统计学意义(P<0.05);且研究组主症及次症分值均明显低于对照组,差异有统计学意义(P<0.05)。治疗后两组患者Scr、BUN、24 h尿蛋白定量均较治疗前降低,差异有统计学意义(P<0.05);且研究组Scr、BUN、24 h尿蛋白定量均明显低于对照组,差异有统计学意义(P<0.05)。治疗后两组患者血清Hcy及IL-6水平均较治疗前降低,差异有统计学意义(P<0.05);且研究组血清Hcy及IL-6水平均明显低于对照组,差异有统计学意义(P<0.05)。治疗期间,研究组不良反应发生率8.89%(4/45)与对照组4.44%(2/45)比较,差异无统计学意义(P>0.05)。结论 常规西药联合滋肾补脾益气合祛湿活血化浊汤治疗DN,可有效缓解患者临床症状,改善肾功能,下调Hcy及IL-6水平,利于提升整体治疗效果,且具有安全性。

从气血论治强直性脊柱炎

气血是形成并保持机体生命运动的基础物质,由脏腑功能运转产生。气血和则百病不生,在强直性脊柱炎的疾病发生、发展过程中,气血变化贯穿始终,体现脏腑功能状态,揭示其发病机理。腰背部疼痛是强直性脊柱炎最主要的临床表现,“不通则痛、不荣则痛”,气血的盛衰决定了其疼痛性质,故从气血辨治强直性脊柱炎有深刻的理论依据及较高的临床应用价值。强直性脊柱炎的主要防治要点为调理脏腑气血的盛衰及活血化瘀,以“补益、理气、活血、化瘀”为治则,以突出脏腑气血治疗特色,临床取得良好疗效。

韩氏中医治疗慢性肝病验案2则

验方攻补汤治疗慢性肝病以疏肝健脾、活血消癥为治疗大法。临证时刻注意攻伐勿过,以健脾疏肝、攻补兼施为大法,重视健脾益气药物的运用,结合疏肝、柔肝、补肝、潜肝阳敛肝阴以防理气药香燥戕害肝体。慢性肝病病程较长,久病穷肾患者多表现为肝肾亏虚的症状,针对这种情况临床重视补肾药物的应用,常用补肾药物有巴戟天、菟丝子、枸杞子、熟地黄等,同时为防止此类药物滋腻碍胃多配伍炒白术、醋青皮等动化药物,以防呆滞。治疗慢性肝病慎用破血逐瘀药,以活血养血滋养肝体为要,治黄勿忘治血,活血以退黄,和肝理脾重视气机,辨病与辨证相结合,分型施治,久病补肾兼以清化。韩氏中医认为肝脾不和、肝郁脾虚是慢性肝病主要病因,故治疗时应时时注意和肝理脾、调畅气机,并注意疏肝解郁,把握病机灵活化裁,标本兼治。气机不通,肝脉瘀阻为慢性肝病的主要病机,治疗应注重理气活血化瘀以阻止和逆转肝硬化,临床时针对肝病患者本虚标实、虚中夹实的病理实质,时刻注意破血药度和量,勿妄用逐瘀之品。依据慢性肝病不同阶段,结合辨证施治,在采用攻补汤治疗的基础上分型施治。文章分析韩氏中医治疗慢性肝病验案2则,以期为相关研究提供参考。

方药联合温针灸治疗脾肾气虚兼血瘀型糖尿病肾病的疗效及对肾脏纤维化指标的影响

目的:观察和分析自拟方药联合温针灸治疗脾肾气虚兼血瘀型糖尿病肾病患者的临床疗效以及对肾脏纤维化指标的影响。方法:选取脾肾气虚兼血瘀型糖尿病肾病患者60例,采取随机数字表法分为对照组和治疗组各30例。对照组予以西医基础治疗加用厄贝沙坦口服;治疗组在对照组基础上予以中药汤剂自拟健脾益肾活血方联合温针灸治疗。两组均以4周为1个疗程,连续治疗2个疗程。比较两组患者经过两个疗程治疗之后的血肌酐(SCr)、尿素氮(BUN)、24小时尿蛋白定量、总胆固醇(TC)、三酰甘油(TG)、空腹血糖(FBG)、糖化血红蛋白(HbA1c)、胱抑素C(CysC)、金属蛋白酶抑制剂-1(TIMP-1)、转化生长因子-β1(TGF-β1)、Ⅳ型胶原(CIV)的变化情况。结果:两组SCr、BUN、24小时尿蛋白定量、TC、TG、FBG、HbA1c、CysC、TIMP-1、TGF-β1、CIV水平均降低(P<0.05),且治疗组指标更低于对照组(P<0.05)。治疗组中医证候疗效评价总有效率明显高于对照组(P<0.05)。结论:自拟健脾益肾活血方联合温针灸治疗可减轻糖尿病肾病肾脏损伤,减轻尿蛋白,延缓肾脏纤维化进展,从而提高患者生存质量。

Efficacy and advantages of modified Traditional Chinese Medicine treatments based on"kidney reinforcing"for chronic aplastic ane-mia:a randomized controlled clinical trial

OBJECTIVE:To compare the efficacy of modified treatments based on "kidney reinforcing" in the management of chronic aplastic anemia(CAA),and explore their advantages and specialties.METHODS:One hundred and eleven patients with CAA were randomly divided into three groups:kidney reinforcing alone(KA),"kidney reinforcing and Qi tonifying"(KQ),and "kidney reinforcing and blood circulation invigorating"(KC).Normal and positive control groups were also formed.All patients were treated for 6 months(two courses).Hemograms,Traditional Chinese Medicine(TCM) syndrome scores,and therapeutic effects were assessed,and changes in T-lymphocyte subsets,regulatory T cells and cytokines were detected.RESULTS:The KQ and KC groups had lower TCM syndrome scores than the positive control group after 6 months(P < 0.05).The KQ group had a higher overall efficacy than the positive control group after 3 months(P < 0.05),while platelet counts increased in the KC group after 6 months(P < 0.05).CD3+ T-lymphocyte ratios decreased only in the KQ group,while CD3 + CD4 + CD8-Tlymphocytes increased only in the KC group after 6 months(P <0.05).Levels of interferon-γ,tumor necrosis fac-tor-α,interleukin(IL)-2 and IL-6 decreased and levels of IL-4 and IL-10 increased in all treated groups after 6 months.Levels of IL-6 in the KQ and KC groups were lower than those in the positive control group(P < 0.05).CONCLUSION:Treatments based on kidney reinforcing have a rebalancing effect on cytotoxic and T helper cells,and regulate expression of interferon-γ,IL-2,IL-6 and IL-4.KQ may be more effective in treating CAA,and KC may have an advantage in platelet recovery.

Study of establishing disease-syndrome combined with animal model for immune thrombocytopenic purpura without additional conditions

Objective:To explore the feasibility of establishing the disease-syndrome combined animal model for immune thrombocytopenic purpura(ITP)without additional conditions.Methods:Three batches of data related to the ITP model mice obtained by replication at different time were analyzed,and whether the APS-injected model mice replicated through the passive immune modeling method could simulate the pathogenesis and clinical characteristics of human ITP was evaluated according to the differentiation criteria for diseasesyndrome combined model.Results:The APS-injected replicated ITP model mice possessed the following traits:(1)Compared with the normal group,the platelet count was significantly decreased,and coagulation time was significantly increased in the model group(P<.01).(2)Compared with the normal group,the medullary thrombocytogenous megakaryocytes were significantly decreased(P<.05,.01,.001).(3)The APS-injected sites and other parts of the model mice had spontaneous hemorrhage.(4)Behavioral changing signs were observed 1 week after the modeling(i.e.low activity,delayed activity,poor appetite,skin petechia/hemorrhage and spontaneous hemorrhage at the injected sites or other parts),and were getting more and more severe.Conclusion:According to the syndrome differentiation criteria for disease-syndrome combined model of ITP,the APS-injected animal model of ITP replicated through the passive immune modeling method without additional conditions possesses the characteristics of disease-syndrome combined model.It provides an ideal tool for the development of traditional Chinese medicine pharmacology experiment.

从“罢极之本”论治甲状腺结节

探讨从“罢极之本”论治甲状腺结节的临床意义,为甲状腺结节治疗拓展思路。通过查阅中医古籍和现代文献,搜集部分医家对“罢极之本”理论的学术观点,探讨“罢极之本”理论内涵,从“罢极之本”提炼甲状腺结节的病因病机、临证思路和用药特色,并附一则医案加以验证。从“罢极之本”探析甲状腺结节病机核心在于肝之体用和生理功能失常为先、肝脏维持脏腑生理功能失常为变,最终导致气滞、血瘀、痰凝壅结颈前发病,关键环节在于“罢极之本”职能特性失常,治疗方面特此提出“肝实者宜疏泄、肝虚者宜柔补”总则,通过疏肝解郁、疏肝活血、培土缓肝、柔肝养血、清肝泻火的不同遣方用药思路而达到散结消瘿的目的,所举验案为肝郁气滞、痰凝血瘀之甲状腺结节,以疏肝理气、化痰活血、软坚散结为治则,方选自拟疏肝散结消瘿方治疗,临床获效显著。从“罢极之本”论治甲状腺结节合理可靠,建立甲状腺结节特色辨治体系,可为今后中医药治疗甲状腺结节提供更为广阔的思路和方法。

孙桂芝治疗食管癌经验总结

孙桂芝教授认为食管癌的病机主要是本虚标实,本虚以脾气亏虚、肝脾不和、脾肾阳虚、肺阴亏虚为主,标实以痰热阻遏,气血运行不畅,阻滞食管气机,日久而为瘀,痰浊瘀热日久化毒,结于食管,形成噎膈。孙教授常以理气化痰活血,调和肝脾,益气健脾,温补脾肾,养阴清肺,软坚解毒抗癌等为治疗原则,配方选药,每获良效。

健脾益气活血汤联合阿仑膦酸钠治疗糖尿病合并骨质疏松症的疗效观察

目的观察健脾益气活血汤联合阿仑膦酸钠治疗糖尿病合并骨质疏松症(DOP)的临床疗效。方法选取2021年6月—2022年6月河北省沧州中西医结合医院内分泌糖尿病科门诊收治的DOP患者106例,采用随机数字表法分为2组。对照组53例给予阿仑膦酸钠片治疗,观察组53例给予健脾益气活血汤内服+阿仑膦酸钠片治疗。6个月后观察2组临床疗效;比较治疗前后2组糖代谢指标[空腹血糖(FPG)、糖化血红蛋白(HbA1c)、空腹胰岛素(FINS)、胰岛素抵抗指数(HOMA-IR)],骨密度,中医证候积分,血液流变学指标[血浆黏度(PV)、全血高切黏度(HBV)、全血低切黏度(LBV)、红细胞聚集指数(EAI)],以及血清骨代谢生化指标[碱性磷酸酶(ALP)、I型原胶原N-端前肽(P1NP)、Ⅰ型胶原交联C-末端肽β-降解产物(β-CTX)],胰岛素样生长因子1(IGF-1),趋化素(Chemerin)水平;统计2组不良反应发生情况。结果观察组总有效率88.68%,高于对照组的73.58%(P<0.05)。治疗后,2组血清FPG、HbA1c、FINS水平及HOMA-IR均较治疗前降低(P<0.05);观察组血清FINS水平及HOMA-IR均低于对照组(P<0.05)。治疗后,2组L1~4骨密度均较治疗前增加(P<0.05),中医证候积分较治疗前降低(P<0.05);观察组L1~4骨密度、中医证候积分与对照组比较,差异有统计学意义(P<0.05)。治疗后,观察组股骨颈、全髋骨密度均高于治疗前(P<0.05),对照组与治疗前比较,差异无统计学意义(P>0.05);2组PV、HBV、LBV、EAI均较治疗前降低(P<0.05),且观察组PV、HBV、LBV、EAI低于对照组(P<0.05);2组血清ALP、P1NP、β-CTX水平均较治疗前降低(P<0.05),且观察组血清ALP、P1NP、β-CTX水平低于对照组(P<0.05)。治疗后,2组血清IGF-1水平较治疗前升高(P<0.05),血清Chemerin水平较治疗前降低(P<0.05);且观察组血清IGF-1水平高于对照组(P<0.05),血清Chemerin水平低于对照组(P<0.05)。治疗过程中,对照组发生恶心1例、头痛1例,观察组发生恶心2例、腹痛1例,2组不良反应发生率差异无统计学意义(P>0.05)。结论健脾益气活血汤联合阿仑膦酸钠治疗DOP的整体疗效确切,其作用可能与该中西医结合方案能有效改善患者胰岛素抵抗、纠正血液流变学异常以及调节血清骨代谢生化指标、IGF-1、Chemerin水平有关。

越南古医籍《海上医宗心领》气血理论探析

《海上医宗心领》是越南后黎朝时期名医黎有卓编撰的一部汉文为主的医学全书。原书纂辑中国历代医学文献精华并注解辨析,同时记载黎有卓临证实践经验。通过对照中国医籍,梳理全书有关气血理论的核心观点,探究渊源和挖掘特色,认为黎有卓博采《黄帝内经》及元明医家的气血学说,深入阐述后天气血与阴阳、水火、脾胃的关系,提出补后天气血为治病求本之法。黎有卓临证首重扶正,善用四君子汤、四物汤等补气血名方,结合具体病证创制后天六味方、后天八味方等补气血新方。全书蕴含的气血理论认识与实践,是中医学体系在域外不同文化背景和历史环境下继承和运用的真实反映,具有本土化特色。